1982
DOI: 10.1002/hep.1840020611
|View full text |Cite
|
Sign up to set email alerts
|

Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: A comparative randomized study

Abstract: Cholesterol gallstones are dissolved in man by chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA). To test the comparative efficacy of these two cholelitholytic bile acids, 223 gallstones patients were randomly treated with either UDCA or CDCA at two different doses: 7 to 8 mg per kg per day and 14 to 15 mg per kg per day. Efficacy and factors influencing dissolution (dose, size of the stones, and time) were evaluated after 3, 6, and 12 months of treatment. UDCA was significantly more efficacious tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
34
1

Year Published

1983
1983
1999
1999

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(39 citation statements)
references
References 30 publications
3
34
1
Order By: Relevance
“…Diarrhea may, therefore, occur under UDCA treatment, although significantly less frequently than with CDCA. This is in agreement with the findings of Roda et al (2). It is important to note that diarrhea occurred, in our study, only (with one exception) in patients treated with the highest doses of UDCA (17 to 19 mg.kg-'-day-'), i.e., doses higher than those usually reported.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Diarrhea may, therefore, occur under UDCA treatment, although significantly less frequently than with CDCA. This is in agreement with the findings of Roda et al (2). It is important to note that diarrhea occurred, in our study, only (with one exception) in patients treated with the highest doses of UDCA (17 to 19 mg.kg-'-day-'), i.e., doses higher than those usually reported.…”
Section: Discussionsupporting
confidence: 93%
“…Several studies have suggested that dissolution was more rapid with UDCA than with CDCA (2,6,14,16,17). In our study, a similar trend was observed, since a higher percentage of patients had signs of dissolution at 6 months with UDCA than with CDCA.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…19 Up to now, the only proven means of preventing gallstone formation during rapid weight loss induced by VLCDs 43,44 or surgical procedures 45,46 has been the administration of ursodeoxycholic acid, an agent known to reduce biliary cholesterol supersaturation. 47 The present results con®rm our previous ®ndings, 21 as well as those recently published by Gebhard et al 22 showing that modi®cation of VLCD fat content, through an effect on gallbladder emptying, may be an effective alternative. In fact, in the present study, the %E was signi®cantly lower in response to stimulation by the low-fat VLCD test meals with respect to those of the high-fat VLCD, at the initial pre-diet evaluation as well as during the diet; this was also demonstrated by Gebhard et al, 22 albeit with a different study design since these authors compared two liquid meals differing in calories and fat content (2.18 MJ (520 Kcal), 2 g fat/d vs 3.77 MJ (900 kcal), 30 g fat/d).…”
Section: Discussionsupporting
confidence: 92%
“…The optimum dose of UDCA has still to be set tled. Gall-stone dissolution has been var iously stated to be better with smaller doses of UDCA [19], to show no difference through a wide range of doses [3,9,23,27] or with larger doses. Several studies have shown pro gressive reduction in biliary cholesterol satu ration with increasing doses of UDCA through the range 150-1,000 mg daily, or equivalent doses reported as milligrammes per kilogramme body weight [5,13,16,24,26],…”
mentioning
confidence: 99%